Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Khurum Khan

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Frontiers in Immunology|April 13, 2026
Editorial: Deciphering the inflammatory response in colorectal and ovarian cancersSherin Bakhashab, Khurum Khan
BMC Medicine|June 11, 2020
COVID-19 cancer conundrum-evidence driving decisions or the lack of it?Nalinie Joharatnam-Hogan, Khurum Khan
Hepatobiliary Surgery and Nutrition|April 26, 2021
Thermal ablation in colorectal liver metastases-the paradox of equipoiseNalinie Joharatnam-Hogan, Khurum Khan
Cancer Treatment Reviews|November 8, 2024
Optimizing outcomes and personalizing care with targeted agents in advanced cholangiocarcinomaUmair Mahmood, Ahmed Abbass, Khurum Khan
Current Drug Targets|March 27, 2015
Targeting Angiogenic Pathways in Colorectal Cancer: Complexities, Challenges and Future DirectionsKhurum Khan, David Cunningham, Ian Chau
Annals of Translational Medicine|June 19, 2018
Translational research and application of basic biology to clinical trial development in GI cancersElizabeth Smyth, Khurum Khan, Nicola Valeri
Journal of Gastrointestinal Oncology|March 12, 2026
Bevacizumab in biliary tract cancer: a clinical catalyst in the era of chemo-immunotherapy?Umair Mahmood, Umer Khan, Khurum Khan
Cancer Treatment Reviews|May 4, 2024
Neoadjuvant management of locally advanced pancreatic ductal adenocarcinoma - Heading towards a promising change in treatment paradigmUmair Mahmood, Ewa Carrier, Khurum Khan
JAMA Oncology|February 13, 2016
AREG and EREG as Predictive Biomarkers for RAS Wild-Type Colorectal Cancer Treated With Panitumumab: A Fresh Approach to an Old PuzzleElizabeth C Smyth, Khurum Khan, David Cunningham
Translational Gastroenterology and Hepatology|August 4, 2025
Is BEER the answer?-non-immunotherapeutic targeted maintenance treatment of chemotherapy-responsive advanced biliary tract cancersUmair Mahmood, Alex B Munster, Khurum Khan
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Frontiers in Immunology|April 13, 2026
Editorial: Deciphering the inflammatory response in colorectal and ovarian cancersSherin Bakhashab, Khurum Khan
BMC Medicine|June 11, 2020
COVID-19 cancer conundrum-evidence driving decisions or the lack of it?Nalinie Joharatnam-Hogan, Khurum Khan
Hepatobiliary Surgery and Nutrition|April 26, 2021
Thermal ablation in colorectal liver metastases-the paradox of equipoiseNalinie Joharatnam-Hogan, Khurum Khan
Cancer Treatment Reviews|November 8, 2024
Optimizing outcomes and personalizing care with targeted agents in advanced cholangiocarcinomaUmair Mahmood, Ahmed Abbass, Khurum Khan
Current Drug Targets|March 27, 2015
Targeting Angiogenic Pathways in Colorectal Cancer: Complexities, Challenges and Future DirectionsKhurum Khan, David Cunningham, Ian Chau
Annals of Translational Medicine|June 19, 2018
Translational research and application of basic biology to clinical trial development in GI cancersElizabeth Smyth, Khurum Khan, Nicola Valeri
Journal of Gastrointestinal Oncology|March 12, 2026
Bevacizumab in biliary tract cancer: a clinical catalyst in the era of chemo-immunotherapy?Umair Mahmood, Umer Khan, Khurum Khan
Cancer Treatment Reviews|May 4, 2024
Neoadjuvant management of locally advanced pancreatic ductal adenocarcinoma - Heading towards a promising change in treatment paradigmUmair Mahmood, Ewa Carrier, Khurum Khan
JAMA Oncology|February 13, 2016
AREG and EREG as Predictive Biomarkers for RAS Wild-Type Colorectal Cancer Treated With Panitumumab: A Fresh Approach to an Old PuzzleElizabeth C Smyth, Khurum Khan, David Cunningham
Translational Gastroenterology and Hepatology|August 4, 2025
Is BEER the answer?-non-immunotherapeutic targeted maintenance treatment of chemotherapy-responsive advanced biliary tract cancersUmair Mahmood, Alex B Munster, Khurum Khan
Pageof 6